Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-07-01T20:13:19.650Z Has data issue: false hasContentIssue false
  • English
  • Français

Age Limit Does Not Replace Serologic Testing for Determination of Immune Status for Measles

Published online by Cambridge University Press:  02 January 2015

Ilker Uçkay ,
Stéphane Hugonnet ,
Laurent Kaiser ,
Hugo Sax  and
Didier Pittet
Ilker Uçkay
Affiliation:
Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland
Stéphane Hugonnet
Affiliation:
Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland
Laurent Kaiser
Affiliation:
Laboratory of Virology, University of Geneva Hospitals, Geneva, Switzerland
Hugo Sax
Affiliation:
Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland
Didier Pittet*
Affiliation:
Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland
*
Director, Infection Control Program, University of Geneva Hospitals, 24 Rue Micheli-du-Crest, 1211 Geneva 14, Switzerland (didier.pittet@hcuge.ch)
Get access Rights & Permissions [Opens in a new window]

Abstract

Adults more than 40 years old are not necessarily immune to measles. A measles outbreak that involved healthcare workers occurred after contact with a 44-year-old patient. Results of a hospitalwide program of mass screening revealed that 117 (4.5%) of 2,600 individuals tested seronegative for measles; 31 (26.1%) of these 117 individuals were more than 40 years old.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 9 , September 2007 , pp. 1117 - 1120
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Steingart, KR, Thomas, AR, Dykewicz, CA, Redd, SC. Transmission of measles virus in healthcare settings during a community-wide outbreak. Infect Control Hosp Epidemiol 1999;20:115–119.CrossRefGoogle Scholar
2. Swiss Federal Office of Public Health. Eidgenössische Komission für Impffragen (EKIF). Schweizerischer Impfplan 2006. Richtinien und Empfehlungen. Bern: Swiss Federal Office of Public Health; 2006.Google Scholar
3. Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997;46(RR-18):1–42.Google Scholar
4. Ljungman, P, Aschan, J, Barkholt, L, et al. Measles immunity after allogeneic stem cell transplantation: influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Bone Marrow Transplant 2004;34:589–593.CrossRefGoogle ScholarPubMed
5. Kremer, JR, Schneider, F, Muller, CP. Waning antibodies in measles and rubella vaccines—a longitudinal study. Vaccine 2006;24:2594–2601.CrossRefGoogle Scholar
6. Dhiman, N, Ovsyannikova, IG, Ryan, JE, et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin Exp Immunol 2005;142:498–504.CrossRefGoogle ScholarPubMed
7. Masserey, E, Bouvier, P, Brenner, E, et al. Vaccinal coverage and its determinants in preschool children in Vaud canton in 1996. Rev Med Suisse Romande 1998;118:309–315.Google ScholarPubMed
8. Anderson, RM, May, RM. Immunisation and herd immunity. Lancet 1990;335:641–645.CrossRefGoogle ScholarPubMed
9. Çelikbaş, A, Ergonul, O, Aksaray, S, et al. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Am J Infect Control 2006;34:583–587.CrossRefGoogle ScholarPubMed
10. Hatakeyama, S, Moriya, K, Itoyama, S, et al. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan. Infect Control Hosp Epidemiol 2004;25:591–594.CrossRefGoogle ScholarPubMed
11. Ammari, LK, Bell, LM, Hodinka, RL. Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infect Control Hosp Epidemiol 1993;14:81–86.CrossRefGoogle ScholarPubMed
12. Ferson, MJ. Control of infections in child care. Med J Aust 1994;161:615–618.CrossRefGoogle ScholarPubMed
13. Fedeli, U, Zanetti, C, Saia, B. Susceptibility of healthcare workers to measles, mumps, rubella and varicella. J Hosp Infect 2002;51:133–135.CrossRefGoogle ScholarPubMed
14. Ziegler, E, Roth, C, Wreghitt, T. Prevalence of measles susceptibility among health care workers in a UK hospital: does the UK need to introduce a measles policy for its health care workers? Occup Med (Lond) 2003;53:398–402.CrossRefGoogle Scholar
15. Willy, ME, Koziol, DE, Fleisher, T, et al. Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol 1994;15:12–17.CrossRefGoogle Scholar
16. Kim, M, LaPointe, J, Liu, FJ. Epidemiology of measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol 1992;13:399–402.CrossRefGoogle Scholar
17. Asari, S, Deguchi, M, Tahara, K, et al. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control 2003;31:157–162.CrossRefGoogle Scholar
18. Seo, SK, Malak, SF, Lim, S, Eagan, J, Sepkowitz, KA. Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1998-1999. Infect Control Hosp Epidemiol 2002;23:276–278.CrossRefGoogle Scholar
19. Wright, LJ, Carlquist, JF. Measles immunity in employees of a multihospital healthcare provider. Infect Control Hosp Epidemiol 1994;15:8–11.CrossRefGoogle ScholarPubMed
20. Almuneef, MA, Memish, ZA, Balkhy, HH, Otaibi, B, Helmi, M. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol 2006;27:1178–1183.CrossRefGoogle Scholar
21. Krause, PJ, Gross, PA, Barrett, TL, et al. Quality standard for assurance of measles immunity among health care workers. Infectious Diseases Society of America. Clin Infect Dis 1994;18:431–436.CrossRefGoogle ScholarPubMed
22. Mühlemann, K, Aebi, C, Zysset, F, Francioli, P. Vaccination du personnel hospitalier contre la rougeole, les oreillons et la rubéole. Swiss-NOSO Bulletin 2001;8:13–15. Available at: http://www.swiss-noso.ch. Accessed June 27, 2007.Google Scholar